What were they thinking? Cognitive states may influence [11C]raclopride binding potential in the striatum
- PMID: 18060695
- PMCID: PMC2276609
- DOI: 10.1016/j.neulet.2007.10.017
What were they thinking? Cognitive states may influence [11C]raclopride binding potential in the striatum
Abstract
[(11)C]Raclopride ([(11)C]RAC) is a selective dopamine D(2)/D(3) antagonist that is commonly used in positron emission tomography (PET) studies to assess both basal levels of receptor availability and changes in availability caused by alterations in striatal dopamine concentration. When designing [(11)C]RAC studies, it is important to understand what variables may affect the results. Here, we examined differences in baseline striatal [(11)C]RAC binding potential (BP(ND)) under two different "rest" conditions. Thirteen subjects received [(11)C]RAC scans. Eight subjects were aware prior to initiation of scanning that they would receive a "baseline" scan, and that no additional procedures would take place during the scan ("certain rest" group, CER). Five subjects were informed that they might or might not receive an i.v. alcohol infusion during the scan ("uncertain rest" group, UNC). This group was informed five min after scan start that they would not receive alcohol. Voxel-wise analyses of binding potential (BP(ND)) images generated for both "rest" conditions indicated that receptor availability was higher in UNC than in CER. This result was confirmed by a region-of-interest analysis, which indicated that the average BP(ND) in right and left putamen was statistically higher in UNC. There were no differences in groups with respect to age or raclopride mass dose that could account for the difference in D(2)/D(3) receptor availability. Our findings suggest that even slight differences in cognitive states between groups can have an effect on BP(ND), presumably mediated by changes in endogenous dopamine concentration.
Figures
Similar articles
-
Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.Hum Brain Mapp. 2015 Jul;36(7):2592-601. doi: 10.1002/hbm.22793. Epub 2015 Mar 18. Hum Brain Mapp. 2015. PMID: 25788222 Free PMC article.
-
Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.Eur Neuropsychopharmacol. 2013 Nov;23(11):1423-31. doi: 10.1016/j.euroneuro.2013.05.012. Epub 2013 Jul 19. Eur Neuropsychopharmacol. 2013. PMID: 23876376
-
[11 C]raclopride positron emission tomography study of dopamine-D2/3 receptor binding in patients with severe major depressive episodes before and after electroconvulsive therapy and compared to control subjects.Psychiatry Clin Neurosci. 2020 Apr;74(4):263-269. doi: 10.1111/pcn.12980. Epub 2020 Feb 7. Psychiatry Clin Neurosci. 2020. PMID: 31943514
-
Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.Psychopharmacology (Berl). 2008 May;197(4):581-90. doi: 10.1007/s00213-008-1088-9. Epub 2008 Feb 5. Psychopharmacology (Berl). 2008. PMID: 18251011
-
Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.Synapse. 2006 Dec 1;60(7):485-95. doi: 10.1002/syn.20325. Synapse. 2006. PMID: 16952157
Cited by
-
Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain.J Neurosci. 2012 May 9;32(19):6711-7. doi: 10.1523/JNEUROSCI.0045-12.2012. J Neurosci. 2012. PMID: 22573693 Free PMC article.
-
Progress in the Stereoselective Synthesis Methods of Pyrrolidine-Containing Drugs and Their Precursors.Int J Mol Sci. 2024 Oct 17;25(20):11158. doi: 10.3390/ijms252011158. Int J Mol Sci. 2024. PMID: 39456938 Free PMC article. Review.
-
The dopaminergic basis of human behaviors: A review of molecular imaging studies.Neurosci Biobehav Rev. 2009 Jul;33(7):1109-32. doi: 10.1016/j.neubiorev.2009.05.005. Epub 2009 May 27. Neurosci Biobehav Rev. 2009. PMID: 19481108 Free PMC article. Review.
-
Latent-Profile Analysis Reveals Behavioral and Brain Correlates of Dopamine-Cognition Associations.Cereb Cortex. 2018 Nov 1;28(11):3894-3907. doi: 10.1093/cercor/bhx253. Cereb Cortex. 2018. PMID: 29028935 Free PMC article.
-
Transient equilibrium determination of dopamine D2/D3 receptor densities and affinities in brain.Front Nucl Med. 2022;2:1030387. doi: 10.3389/fnume.2022.1030387. Epub 2022 Dec 1. Front Nucl Med. 2022. PMID: 36926525 Free PMC article.
References
-
- Alpert NM, Badgaiyan RD, Livni E, Fischman AJ. A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems. Neuroimage. 2003;19:1049–60. - PubMed
-
- Andersson JL, Marcus M, Nomikos GG, Svensson TH. Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system. Naunyn Schmiedebergs Arch Pharmacol. 1994;349:236–43. - PubMed
-
- Antonini A, Leenders KL, Reist H, Thomann R, Beer HF, Locher J. Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride. Arch Neurol. 1993;50:474–80. - PubMed
-
- Christian BT, Narayanan T, Shi B, Morris ED, Mantil J, Mukherjee J. Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol. J Cereb Blood Flow Metab. 2004;24:309–22. - PubMed
-
- Costes N, Merlet I, Ostrowsky K, Faillenot I, Lavenne F, Zimmer L, Ryvlin P, Le Bars D. A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging. J Nucl Med. 2005;46:1980–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
